MSN: Researchers study how immunotherapy affects COVID-19 outcomes
MSN highlighted recent research from the University of Cincinnati Cancer Center on how immunotherapy treatments and immunosuppression affects the severity of COVID-19 infections for patients with cancer.
Trisha Wise-Draper, MD, PhD, co-led the research that was recently published in JAMA Oncology.
"We reviewed patients with cancer, those that had baseline immunosuppression, and those that were treated with immunotherapy prior to getting COVID-19," said Wise-Draper, associate professor of medicine in the Division of Hematology/Oncology, section head for Medical Oncology in UC’s College of Medicine, Head and Neck Center of Excellence co-leader and a UC Health physician. "The most important finding is that although those treated with immunotherapy alone did not have an effect on COVID-19 disease outcomes, those that had baseline immunosuppression and were treated with immunotherapy had worse outcomes with COVID-19."
Related Stories
UC named a best employer in Ohio by Forbes
August 14, 2026
Forbes ranks the University of Cincinnati No. 24 on its 2026 America’s Best Employers By State list for Ohio, recognizing UC’s strong workplace culture and employee experience.
Mistakes to avoid when shopping for a product dupe
August 13, 2026
The University of Cincinnati’s Kelly Dobos was featured in an AARP article discussing ways to determine if “dupe” cosmetic products really are comparable to the more expensive name brand.
Ancient warming event hints at potential climate tipping point
August 12, 2026
Researchers say a spike in temperatures during an ice age 304 million years ago could inform what climate scientists are learning about rapidly changing conditions today.